Reduced tumor vessel density and high expression of glucose transporter 1 suggest tumor hypoxia of squamous cell carcinoma of the esophagus surviving after radiotherapy

Surgery - Tập 137 - Trang 536-544 - 2005
Yuichiro Doki1, Ko Takachi1, Osamu Ishikawa1, Yo Sasaki1, Isao Miyashiro1, Hiroaki Ohigashi1, Masahiko Yano1, Ryu Ishihara2, Yoshitane Tsukamoto3, Kinji Nishiyama4, Shingo Ishiguro1, Shingi Imaoka1
1From the Department of Digestive Surgery
2Gastrointestinal Oncology
3Pathological Diagnosis
4Radiation Oncology, Osaka Medical Center for Cancer and Cardiovascular Diseases

Tài liệu tham khảo

Minsky, 2002, INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy, J Clin Oncol, 20, 1167, 10.1200/JCO.20.5.1167 Hironaka, 2003, Nonrandomized comparison between definitive chemoradiotherapy and radical surgery in patients with T(2-3)N(any) M(0) squamous cell carcinoma of the esophagus, Int J Radiat Oncol Biol Phys, 57, 425, 10.1016/S0360-3016(03)00585-6 Chan, 1999, Is combined chemotherapy and radiation therapy equally effective as surgical resection in localized esophageal carcinoma?, Int J Radiat Oncol Biol Phys, 45, 265, 10.1016/S0360-3016(99)00199-6 Urschel, 2003, Complications of salvage esophagectomy, Med Sci Monit, 9, RA173 Swisher, 2002, Salvage esophagectomy for recurrent tumors after definitive chemotherapy and radiotherapy, J Thorac Cardiovasc Surg, 123, 175, 10.1067/mtc.2002.119070 Stein, 2001, Esophageal carcinoma: 2-stage operation for preventing mediastinitis in high risk patients, Chirurg, 72, 881, 10.1007/s001040170083 Sakuraba, 2004, Importance of additional microvascular anastomosis in esophageal reconstruction after salvage esophagectomy, Plast Reconstr Surg, 113, 1934, 10.1097/01.PRS.0000122211.29839.FE Yamamoto, 2000, Evaluation of the histologic effect of chemoradiation therapy for squamous cell carcinomas of the esophagus by assessing morphologic features of surgical specimens, Dis Esophagus, 13, 293, 10.1046/j.1442-2050.2000.00136.x Yang, 2004, Significance of post-chemoradiation biopsy in predicting residual esophageal carcinoma in the surgical specimen, Dis Esophagus, 17, 38, 10.1111/j.1442-2050.2004.00355.x Weinmann, 2004, Tumour hypoxia: impact on biology, prognosis and treatment of solid malignant tumours, Onkologie, 27, 83, 10.1159/000075611 Denko, 2003, Investigating hypoxic tumor physiology through gene expression patterns, Oncogene, 22, 5907, 10.1038/sj.onc.1206703 Perez, 2003 Krishnamachary, 2003, Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1, Cancer Res, 63, 1138 Pennacchietti, 2003, Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene, Cancer Cell, 3, 347, 10.1016/S1535-6108(03)00085-0 Ohtsu, 1999, Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus, J Clin Oncol, 17, 2915, 10.1200/JCO.1999.17.9.2915 Yano, 1999, Concurrent chemotherapy (5-fluorouracil and cisplatin) and radiation therapy followed by surgery for T4 squamous cell carcinoma of the esophagus, J Surg Oncol, 70, 25, 10.1002/(SICI)1096-9098(199901)70:1<25::AID-JSO5>3.0.CO;2-M Sobin, 2002 Doki, 2003, Possible indication for surgical treatment of squamous cell carcinomas of the esophagus that involve the stomach, Surgery, 133, 479, 10.1067/msy.2003.134 Doki, 2001, Does pleural lavage cytology before thoracic closure predict both patient's prognosis and site of cancer recurrence after resection of esophageal cancer?, Surgery, 130, 792, 10.1067/msy.2001.117195 Kabuto, 1999, Combined resection of the aorta for an esophageal carcinoma invading the aorta through a right transthoracic approach, Jpn J Thorac Cardiovasc Surg, 47, 611, 10.1007/BF03218073 Yasuda, 1995, Preoperative neoadjuvant chemotherapy with a combination of 5-fluorouracil, adriamycin and cisplatin (FAP) for advanced esophageal cancer invading trachea or main bronchus, Gan To Kagaku Ryoho, 22, 1538 Kato, 2001, Expression of nitrotyrosine is associated with angiogenesis in esophageal squamous cell carcinoma, Anticancer Res, 21, 3323 Kato, 2003, Correlation of 18-F-fluorodeoxyglucose (FDG) accumulation with glucose transporter (Glut-1) expression in esophageal squamous cell carcinoma, Anticancer Res, 23, 3263 Miyata, 2000, CDC25B and p53 are independently implicated in radiation sensitivity for human esophageal cancers, Clin Cancer Res, 6, 4859 Kishi, 2002, Prediction of the response to chemoradiation and prognosis in oesophageal squamous cancer, Br J Surg, 89, 597, 10.1046/j.1365-2168.2002.02057.x Takeuchi, 2003, Cell-cycle regulators and the Ki-67 labeling index can predict the response to chemoradiotherapy and the survival of patients with locally advanced squamous cell carcinoma of the esophagus, Ann Surg Oncol, 10, 792, 10.1245/ASO.2003.10.014 Garcia-Barros, 2003, Tumor response to radiotherapy regulated by endothelial cell apoptosis, Science, 300, 1155, 10.1126/science.1082504 Mauceri, 1998, Combined effects of angiostatin and ionizing radiation in antitumour therapy, Nature, 394, 287, 10.1038/28412 Hironaka, 2002, Biopsy specimen microvessel density is a useful prognostic marker in patients with T(2-4)M(0) esophageal cancer treated with chemoradiotherapy, Clin Cancer Res, 8, 124 Airley, 2003, GLUT-1 and CAIX as intrinsic markers of hypoxia in carcinoma of the cervix: relationship to pimonidazole binding, Int J Cancer, 104, 85, 10.1002/ijc.10904 Sohda, 2004, Pretreatment evaluation of combined HIF-1alpha, p53 and p21 expression is a useful and sensitive indicator of response to radiation and chemotherapy in esophageal cancer, Int J Cancer, 110, 838, 10.1002/ijc.20215 Wieder, 2004, Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment, J Clin Oncol, 22, 900, 10.1200/JCO.2004.07.122 Imai, 2003, Hypoxia attenuates the expression of E-cadherin via up-regulation of SNAIL in ovarian carcinoma cells, Am J Pathol, 163, 1437, 10.1016/S0002-9440(10)63501-8 Okami, 2004, Silencing of the hypoxia-inducible cell death protein BNIP3 in pancreatic cancer, Cancer Res, 64, 5338, 10.1158/0008-5472.CAN-04-0089 Imdahl, 2000, Is MIB-1 proliferation index a predictor for response to neoadjuvant therapy in patients with esophageal cancer?, Am J Surg, 179, 514, 10.1016/S0002-9610(00)00386-X